000 01740 a2200529 4500
005 20250517061242.0
264 0 _c20160602
008 201606s 0 0 eng d
022 _a1096-8652
024 7 _a10.1002/ajh.24228
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTavitian, Suzanne
245 0 0 _aImpact of obesity in favorable-risk AML patients receiving intensive chemotherapy.
_h[electronic resource]
260 _bAmerican journal of hematology
_cFeb 2016
300 _a193-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aBody Mass Index
650 0 4 _aBody Surface Area
650 0 4 _aDisease-Free Survival
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInduction Chemotherapy
650 0 4 _aLeukemia, Myeloid, Acute
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aObesity
_xcomplications
650 0 4 _aRetrospective Studies
650 0 4 _aRisk
650 0 4 _aTreatment Outcome
700 1 _aDenis, Amélia
700 1 _aVergez, François
700 1 _aBerard, Emilie
700 1 _aSarry, Audrey
700 1 _aHuynh, Anne
700 1 _aDelabesse, Eric
700 1 _aLuquet, Isabelle
700 1 _aHuguet, Françoise
700 1 _aRécher, Christian
700 1 _aBertoli, Sarah
773 0 _tAmerican journal of hematology
_gvol. 91
_gno. 2
_gp. 193-8
856 4 0 _uhttps://doi.org/10.1002/ajh.24228
_zAvailable from publisher's website
999 _c25395123
_d25395123